
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 1 41-46, Copyright © 1993 by American Association for Cancer Research
ARTICLES |
LC Clark, LJ Hixson, GF Combs Jr, ME Reid, BW Turnbull and RE Sampliner
Department of Family and Community Medicine, University of Arizona College of Medicine, Tucson 85716.
The objective of this cross-sectional study was to determine whether plasma selenium concentration predicts the prevalence of adenomatous polyps of the colon and rectum. The source population for the study was 101 patients undergoing sequential colonoscopies at the Veterans Affairs Medical Center, Tucson, AZ. The study population was then limited to the 48 patients (all male) undergoing their initial colonoscopy who did not have a diagnosis of colorectal cancer. For each of these patients, a prediagnostic fasting plasma selenium concentration was determined. The data from this study suggest that fasting plasma selenium concentrations may be an important risk factor for colorectal adenomas. Patients with fasting plasma selenium concentrations below the median (< 128 mcg/liter) were significantly more likely to have one or more adenomatous polyps (prevalence odds ratio 4.2) and more adenomatous polyps (3.5 times) per patient. There was also a suggestion of a more proximal distribution of adenomatous polyps in the patients with a lower level of selenium. These associations were not confounded by age or smoking. The results of this study are consistent with the experimental animal studies, geographic mortality studies, and prospective cohort studies of selenium and colorectal cancer.
This article has been cited by other articles:
![]() |
U. Peters, N. Chatterjee, R. B. Hayes, R. E. Schoen, Y. Wang, S. J. Chanock, and C. B. Foster Variation in the Selenoenzyme Genes and Risk of Advanced Distal Colorectal Adenoma Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1144 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Peters, N. Chatterjee, T. R. Church, C. Mayo, S. Sturup, C. B. Foster, A. Schatzkin, and R. B. Hayes High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 315 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. NELSON, A.-C. GOULET, E. T. JACOBS, and P. LANCE Studies into the Anticancer Effects of Selenomethionine against Human Colon Cancer Ann. N.Y. Acad. Sci., November 1, 2005; 1059(1): 26 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Hawk and B. Levin Colorectal Cancer Prevention J. Clin. Oncol., January 10, 2005; 23(2): 378 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Duffield-Lillico, I. Shureiqi, and S. M. Lippman Can Selenium Prevent Colorectal Cancer? A Signpost From Epidemiology J Natl Cancer Inst, November 17, 2004; 96(22): 1645 - 1647. [Full Text] [PDF] |
||||
![]() |
E. T. Jacobs, R. Jiang, D. S. Alberts, E. R. Greenberg, E. W. Gunter, M. R. Karagas, E. Lanza, L. Ratnasinghe, M. E. Reid, A. Schatzkin, et al. Selenium and Colorectal Adenoma: Results of a Pooled Analysis J Natl Cancer Inst, November 17, 2004; 96(22): 1669 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wallace, T. Byers, J. S. Morris, B. F. Cole, E. R. Greenberg, J. A. Baron, A. Gudino, V. Spate, and M. R. Karagas Prediagnostic Serum Selenium Concentration and the Risk of Recurrent Colorectal Adenoma: A Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 464 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, S. S. Mikhail, Y. W. Ding, G.-y. Yang, F. Bondoc, and C. S. Yang Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats Carcinogenesis, August 1, 2000; 21(8): 1531 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ip Lessons from Basic Research in Selenium and Cancer Prevention J. Nutr., November 1, 1998; 128(11): 1845 - 1854. [Abstract] [Full Text] |
||||
![]() |
M LANGMAN and P BOYLE Chemoprevention of colorectal cancer Gut, October 1, 1998; 43(4): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |